Home Nucleus Oncology Russia Non-Small Cell Lung Cancer Diagnostics Market to 2032

Russia Non-Small Cell Lung Cancer Diagnostics Market to 2032

Overview

The Russia Non-Small Cell Lung Cancer Diagnostics Market is expected to reach a 151.25 USD Million by 2032 and is projected to grow at a CAGR of 19.95% from 2025 to 2032.

Revenue, 2024 (USD Million)
59.20
Forecast, 2032 (USD Million)
151.25
CAGR, 2024 - 2032
19.95%
Report Coverage
Russia

Russia Non-Small Cell Lung Cancer Diagnostics Market 2018-2032 USD Million

Russia Non-Small Cell Lung Cancer Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 59.20 USD Million
  • Projected Market Size (2032): 151.25 USD Million
  • CAGR (2025-2032): 19.95%

Key Findings of Russia Non-Small Cell Lung Cancer Diagnostics Market

  • The Russia Non-Small Cell Lung Cancer Diagnostics Market was valued at 59.20 USD Million in 2024.
  • The Russia Non-Small Cell Lung Cancer Diagnostics Market is likely to grow at a CAGR of 19.95% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Lung Adenocarcinoma (LUAD) in Lung Cancer Type Segment accounted for the largest share of the market with a revenue of 31.48 USD Million
  • The fastest growing segment Imaging Test in Test Segment grew Fastest with a CAGR of 23.36% during the forecast period from 2024 to 2032.

Russia Non-Small Cell Lung Cancer Diagnostics Market Scope

Russia Non-Small Cell Lung Cancer Diagnostics Market Segmentation & Scope
Test
  • Thorecentesis
  • Sputum Cytology
  • Biopsy
  • Others
  • Immunohistochemistry
  • Imaging Test
  • Molecular Test
End User
  • Institutes and Research Centers
  • Academics
  • Hospital
  • Clinical Laboratories
Lung Cancer Type
  • Others
  • Large Cell Carcinoma
  • Lung Squamous CellCarcinoma (LUSC)
  • Lung Adenocarcinoma (LUAD)
Product
  • Services and Softwares
  • Reagents and Kits
  • Instruments

Russia Non-Small Cell Lung Cancer Diagnostics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Million
Market Value in 2024 59.20 USD Million
Market Value in 2032 151.25 USD Million
CAGR (2025-2032) 19.95%
Historic Data 2016-2023
Market Segments Covered Test,End User,Lung Cancer Type,Product

Regional Insights:

  • Leading Market (2024-2032): Russia, leading in terms of revenue 59.20 USD Million in 2024
    • Key Country: Russia, leading in terms of revenue with value of 59.20 USD Million in 2024.

Segments and Scope

  • Russia Non-Small Cell Lung Cancer Diagnostics Market to 2032, By Test
    • Molecular Test is the largest segment in Russia Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a revenue of 30.40 USD Million in the year 2024.
    • Imaging Test is the Fastest growing segment in Russia Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a Growth rate of 19.10 % in forecast period 2025-2032.
  • Russia Non-Small Cell Lung Cancer Diagnostics Market to 2032, By End User
    • Clinical Laboratories is the largest segment in Russia Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a revenue of 23.46 USD Million in the year 2024.
    • Clinical Laboratories is the Fastest growing segment in Russia Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a Growth rate of 21.14 % in forecast period 2025-2032.
  • Russia Non-Small Cell Lung Cancer Diagnostics Market to 2032, By Lung Cancer Type
    • Lung Adenocarcinoma (LUAD) is the largest segment in Russia Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a revenue of 31.48 USD Million in the year 2024.
    • Lung Adenocarcinoma (LUAD) is the Fastest growing segment in Russia Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a Growth rate of 20.42 % in forecast period 2025-2032.
  • Russia Non-Small Cell Lung Cancer Diagnostics Market to 2032, By Product
    • Instruments is the largest segment in Russia Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a revenue of 27.35 USD Million in the year 2024.
    • Reagents and Kits is the Fastest growing segment in Russia Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a Growth rate of 19.51 % in forecast period 2025-2032.

Russia Non-Small Cell Lung Cancer Diagnostics Market Company Share Analysis

 
Company Name Company Share Analysis
QIAGEN
Quest Diagnostics Incorporated
Abbott
General Electric
F. Hoffmann-La Roche Ltd.
Russia Non-Small Cell Lung Cancer Diagnostics Market Company Share Analysis

Russia Non-Small Cell Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

Russia Non-Small Cell Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

Russia Non-Small Cell Lung Cancer Diagnostics Market Company Profiling

Russia Non-Small Cell Lung Cancer Diagnostics Market Company Profiling

Industry Related Reports

Asia-Pacific Breast Lesion Localization Methods Market
Europe Breast Lesion Localization Methods Market
North America Breast Lesion Localization Methods Market
Middle East & Africa Breast Lesion Localization Methods Market
South America Breast Lesion Localization Methods Market
Australia Breast Lesion Localization Methods Market
Belgium Breast Lesion Localization Methods Market
Brazil Breast Lesion Localization Methods Market
Canada Breast Lesion Localization Methods Market
China Breast Lesion Localization Methods Market
Frequently Asked Questions
The Russia Non-Small Cell Lung Cancer Diagnostics Market is segmented based on Segmentation Test,End User,Lung Cancer Type,Product.
Russia Non-Small Cell Lung Cancer Diagnostics Market was valued at USD 59.20(Revenue in USD Million) in 2020.
Russia Non-Small Cell Lung Cancer Diagnostics Market is projected to grow at a CAGR of 19.95% during the forecast period of 2024 to 2032.
The Lung Adenocarcinoma (LUAD) segment is expected to dominate the Russia Non-Small Cell Lung Cancer Diagnostics Market, holding a largest market share of 31.48 USD Million in 2024

Russia Non-Small Cell Lung Cancer Diagnostics Market Scope

Russia Non-Small Cell Lung Cancer Diagnostics Market Segmentation & Scope
Test
  • Thorecentesis
  • Sputum Cytology
  • Biopsy
  • Others
  • Immunohistochemistry
  • Imaging Test
  • Molecular Test
End User
  • Institutes and Research Centers
  • Academics
  • Hospital
  • Clinical Laboratories
Lung Cancer Type
  • Others
  • Large Cell Carcinoma
  • Lung Squamous CellCarcinoma (LUSC)
  • Lung Adenocarcinoma (LUAD)
Product
  • Services and Softwares
  • Reagents and Kits
  • Instruments
Frequently Asked Questions
The Russia Non-Small Cell Lung Cancer Diagnostics Market is segmented based on Segmentation Test,End User,Lung Cancer Type,Product.
Russia Non-Small Cell Lung Cancer Diagnostics Market was valued at USD 59.20(Revenue in USD Million) in 2020.
Russia Non-Small Cell Lung Cancer Diagnostics Market is projected to grow at a CAGR of 19.95% during the forecast period of 2024 to 2032.
The estimated market value of the Russia Non-Small Cell Lung Cancer Diagnostics Market for final year is USD 151.25 (USD Million).

Russia Non-Small Cell Lung Cancer Diagnostics Market Company Profiling

Russia Non-Small Cell Lung Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The Russia Non-Small Cell Lung Cancer Diagnostics Market is segmented based on Segmentation Test,End User,Lung Cancer Type,Product.
Russia Non-Small Cell Lung Cancer Diagnostics Market was valued at USD 59.20(Revenue in USD Million) in 2020.
Russia Non-Small Cell Lung Cancer Diagnostics Market is projected to grow at a CAGR of 19.95% during the forecast period of 2024 to 2032.
The estimated market value of the Russia Non-Small Cell Lung Cancer Diagnostics Market for final year is USD 151.25 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES